Labshake search
Citations for Tocris :
51 - 80 of 80 citations for TSLP R Human HEK 293 His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... injected with saline (control) or a range of doses (0.3, 1, 3, or 10mg/kg) of (R)-CPP (Tocris Bioscience ...
-
bioRxiv - Cell Biology 2023Quote: ... Cells were incubated in Anteriorization media-1 (100 ng/ml Noggin (R&D/Biotechne) and 10 μM SB431542 (Tocris)) for 24 hours ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with FGF-2 (20 ng ml−1), Activin-A (50 ng ml−1), BMP-4 (10 ng ml−1, R&D) and LY294002 (10 mM Tocris). Media was changed again after 42 hours to CDM-BSA supplemented with FGF-2 (8 ng ml−1) ...
-
bioRxiv - Neuroscience 2020Quote: ... Intrinsic properties were recorded in the presence of 10 μM biccuculine methiodide (Enzo, Life Sciences) and 10 μM saclofen (R&D, Tocris). We studied only cells with series resistance < 25 MΩ ...
-
bioRxiv - Neuroscience 2019Quote: ... (+)-4-[(αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80) (20mg/kg; Tocris) dissolved in 1mM HCl in saline.
-
bioRxiv - Developmental Biology 2020Quote: ... day 3 NMP-like cultures were treated with Accutase and replated at a density of 45,000 cells/cm2 on Geltrex-coated plates in N2B27 containing FGF2 (40 ng/ml, R&D) and CHIR99021 (8 µM, Tocris) for two days ...
-
bioRxiv - Cell Biology 2021Quote: ... The growth medium was supplemented with 100 ng/mL human recombinant epidermal growth factor (EGF) (R&D) as the major growth-supporting peptide and was further supplemented with 10 µM Y27632 (Tocris), 500 nM A83-01 (Tocris) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and plated at 60,000 cells/cm2 in N2B27 medium supplemented with 20 ng/ml of FGF2 (Cat# 233-FB/CF, R&D) and 4 μM of CHIR 99021 (Cat# 4423, Tocris) and 10 μM of Rock Inhibitor (Y-27632 ...
-
bioRxiv - Neuroscience 2023Quote: ... Slices were continuously perfused with this saline solution during whole-cell recording with the addition of 20 μM NBQX and 20 μM (R)-CPP (Tocris) to isolate inhibitory synaptic activity ...
-
bioRxiv - Cell Biology 2023Quote: ... The indicated drugs were directly added in the culture medium: torin-1 (10 μM) (4247/10, R&D and Tocris), Rotenone (500 nM ...
-
bioRxiv - Cell Biology 2021Quote: ... and human vasopressin type 2 receptor (V2R) with [Arg8]-vasopressin (AVP; Tocris 2935, in water). The transfected β-arrestins are of bovine origin ...
-
bioRxiv - Neuroscience 2021Quote: ... NMDA receptor (R) dependency was tested by application of an NMDAR antagonist (APV 50 µM, DL-2-Amino-5-phosphonopentanoic acid, Tocris, Germany) in the bath solution ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... supplemented with 100 ng/mL Activin A (R&D, Minneapolis, MN, USA) and 3–5 µM CHIR99021 (Tocris Bioscience, Bristol, UK) (differentiation day 0 ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: Lyophilized and HPLC-purified Human β-Amyloid1-42 (Aβ1-42) peptide was purchased from Tocris (#1428). 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP ...
-
bioRxiv - Cell Biology 2021Quote: ... 20ng/ml human LIF (all from WT-MRC Cambridge Stem Cell Institute) and 2µM Gö6983 (Tocris). For PXGL ...
-
bioRxiv - Immunology 2019Quote: ... and grown in B cell growth media to 80% confluence before being treated for 4h with 5μg/ml mitomycin C (Tocris, R&D Systems). Monolayers of growth arrested cells were washed 3 times with PBS ...
-
bioRxiv - Neuroscience 2023Quote: Adherent human iPSCs were grown to near confluence before the differentiation to heterogenous spinal/hindbrain neurons was initiated by changing the media for two days to media d1-2 (200 nM LDN193189 [Tocris, 6053], 10 µM SB431542 [Tocris, 1614], 25 ng/mL SHH-C25II [R&D Systems, 464-SH-025], 250 nM Purmorphamine [Tocris, 4551] ...
-
bioRxiv - Immunology 2023Quote: ... The scFv library was subjected to four rounds of bio-panning against the human Aβ42 peptide (Tocris Bioscience Amyloid β-Peptide 1-42 human ...
-
bioRxiv - Physiology 2024Quote: Overnight recovered mouse or human islets were cultured with 0.1% DMSO (vehicle) or 9 µM AGK2 (Tocris), 25 µM AK-1 (EMD-Millipore) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Human Organoid Growth Medium (HOGM): 50 µl of HOGM consisted of 25 µl A83-01 (1mM, Tocris), 50 µl Human Epidermal Growth Factor (hEGF ...
-
bioRxiv - Bioengineering 2023Quote: ... The supernatant was aspirated and the pellet re-suspended in fresh E8 medium supplemented with 10 µM ROCK inhibitor (Tocris R&D Systems). Re-suspended cells were seeded at a density between 7,500 – 12,500 cells / cm2 on fresh Matrigel-coated plates (Day – 3) ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were resuspended in human embryonic stem cell (hESC) medium without bFGF2 supplemented with 1 µM dorsomorphin (Tocris), 3 µM CHIR99021 (Axon Medchem) ...
-
bioRxiv - Genomics 2019Quote: ... 20ng/ml human LIF (all from WT-MRC Cambridge Stem Cell Institute) and 2 μM Gö6983 (PKCi; Tocris) on Matrigel–coated plates (Corning) ...
-
bioRxiv - Cell Biology 2023Quote: ... 10 nM gastrin, 100 ng/ml recombinant human NRG1 (RD, 5898-NR) and 500 nM A83-01 (Tocris). Human mini-colons were maintained for 14 and 21 days ...
-
bioRxiv - Neuroscience 2019Quote: ... surgeries a single dose (0,6 mg/kg dissolved in phosphate buffer or saline) of P2Y12 receptor (P2Y12R) antagonist (PSB0739 Tocris, R&D Systems, Minneapolis, USA) was administered to the cisterna magna in 5 µl final volume using a glass capillary ...
-
bioRxiv - Developmental Biology 2020Quote: ... cells were treated with 1 µM SB431542 (S4317, MilliporeSigma, Burlington, MA, USA) to inhibit TGFβR1 activity or 3µM SIS3 (5291, Tocris/R&D Systems, Minneapolis, MN, USA) to inhibit SMAD3 solubilized in 50 mM DMSO ...
-
bioRxiv - Immunology 2019Quote: ... To test the effect of VIP on ILC3, cells were incubated with different concentrations of VIP (human, rat, mouse, rabbit, canine, porcine) from Tocris, Bay 55-9837 (Tocris) ...
-
bioRxiv - Cell Biology 2023Quote: ... naïve mGFP+ or YFP+ HFSCs were pretreated with the indicated antagonist (1nM UVI3003; 1uM HX531; 1uM JTE013; 100nM BMS 777607; 1uM AGN 193109) (first four: Tocris Bioscience; last one: R&D Systems) for 30 min prior to corpse or corpse-conditioned media addition ...
-
bioRxiv - Immunology 2020Quote: ... Sigma Aldrich] 30 min prior to activation followed by treatment with 5μg/mL anti-IgM and 1,25μg/mL CpG or were first activated with anti-IgM/CpG for 4h followed by incubation with indicated concentrations of α- or ß-adrenergic receptor (ADR) agonists (ADRA1: (R)-(-)-Phenylephrine hydrochloride (Tocris, Bristol, UK, catalogue number: 2838), ADRA2 ...
-
bioRxiv - Cell Biology 2021Quote: Receptors were stimulated as follows: human Angiotensin 1 receptor (AT1R) with Angiotensin II (AngII; Tocris 4474-91-3, in measuring buffer), human β2 adrenergic receptor (β2ADR ...